Market Context — Why This Technology, Why Now

The global shift towards proactive health management and personalized wellness is accelerating, fueled by rising chronic disease rates and consumer demand for accessible health data. Companies are increasingly investing in 'health-as-a-service' models and corporate wellness programs to improve employee well-being and reduce long-term healthcare expenditures. This technology aligns perfectly with these trends, offering a scalable solution for continuous health monitoring and early intervention.

Key Competitive Advantages
01

Collects health and lifestyle impact information from a single drop of blood by observing red blood cell membrane breakdown, enabling early identification of adverse health risks.

02

Provides a foundation to simultaneously understand the link between health status and lifestyle, which is difficult with conventional tests, facilitating personalized improvement recommendations.

03

Granted patentability after comparison with 7 prior art documents, demonstrating clear differentiation from existing technologies and providing a robust intellectual property foundation.

Market Opportunity
Preventive Medicine and Health Screening
$3.5B globally (AI est.)
Increased prevalence of lifestyle diseases and rising health awareness are expanding the need for early detection and intervention. This technology enables convenient, regular health checks, driving continued market growth.
Large diagnostic laboratories Corporate health solution providers Medical device manufacturers for screening tools
Corporate Wellness and Employee Healthcare
$2B globally (AI est.)
Companies are increasingly viewing employee health as a strategic asset. This technology offers a solution to continuously monitor employee health, potentially boosting productivity and reducing healthcare costs.
HR benefits platform providers Occupational health service companies Large corporations with self-insured health plans
Fitness and Wellness Services
$1.5B globally (AI est.)
Demand for personalized exercise guidance and nutritional management is growing. Utilizing objective biometric data from this technology could enable more effective, customized service offerings.
High-end fitness club chains Personalized nutrition companies Wearable tech companies integrating health data
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

The rapid patent grant in just 8 months, utilizing an accelerated examination system, underscores the technology's novelty and importance. Overcoming a single office action with precise amendments and arguments demonstrates the establishment of clear and effective claim scope, indicating a highly robust patent. This patent protects the information collection method, system, and device across 12 claims, providing broad coverage.

Competitive White Space

This patent primarily covers the method and system for analyzing red blood cell membrane breakdown. White space exists in developing advanced AI/ML models for predictive diagnostics based on this data, integrating with other biometric sensors (e.g., wearables), or creating novel therapeutic interventions informed by the collected health insights.

Economic Impact
~$200K/year estimated health management cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming a company with 1,000 employees adopts this technology for health check-ups. Replacing a portion of conventional detailed examination costs ($100/person/year (AI est.)) with this technology's simplified examination ($35/person/year (AI est.)) could reduce annual examination costs by ~$65K (AI est.). Furthermore, early intervention for severe illness prevention could reduce healthcare burdens ($135/person/year (AI est.)) by 10%, leading to an additional ~$135K (AI est.) annual saving. Total estimated cost reduction is ~$200K/year (AI est.).

Speed to Market
4× faster than in-house development
This technology applies the physical phenomenon of red blood cell membrane breakdown, with its basic principles and observation methods already established. The patent specification also suggests algorithms for information collection, indicating that the foundational research phase is complete. Therefore, licensees would not need to undertake development from scratch, potentially significantly shortening time-to-market by focusing on integrating it as a software module into existing diagnostic equipment or image analysis systems, and developing data linkage interfaces.
Competitive Positioning

X: Ease of Data Acquisition
Y: Comprehensiveness of Health Status

Business Models & Applications
📝 Licensing Model
A model where this technology is licensed to existing medical device manufacturers or health screening service providers, generating royalty revenue. Licensees can rapidly deploy new services.
🤝 Joint Development & OEM Model
A model focused on jointly developing information collection systems or devices specialized for specific health issues with pharmaceutical or food manufacturers, aiming for OEM supply or joint business expansion.
📊 Data Analysis Platform Model
A model for building a platform that anonymizes and aggregates blood data collected by this technology, providing health predictions and personalized advice through AI-driven analysis.
Adjacent Application Opportunities
🏥 Medical Institutions & Clinics
Rapid Screening Diagnostics
Implementing this technology for pre-consultation screening of outpatients could enable early detection of lifestyle-related health risks often missed by questionnaires alone. This could assist physicians in making more accurate diagnoses and treatment plans, potentially reducing patient wait times by ~20% and improving overall patient experience.
💪 Fitness & Personal Training
Personalized Training & Nutrition Guidance
Fitness centers and personal trainers could leverage this technology to objectively understand client lifestyle trends and physical conditions from blood data, enabling highly personalized exercise and nutrition plans. This could significantly enhance client goal attainment and boost client retention by up to 30%.
保険・共済
Risk-Adjusted Insurance Product Development
Insurance providers could use this technology to more accurately assess policyholder health risks related to lifestyle, enabling the development of customized insurance products and incentive programs for health promotion. This could enhance customer engagement and potentially reduce long-term claims costs by 5-10%.
Integration Roadmap — Estimated 15-Month Deployment
Phase 1: Technical Feasibility Assessment & Requirements Definition
Duration: 3 months
Evaluate technical compatibility with the licensee's existing diagnostic equipment and data management systems, then define detailed functional requirements, performance targets, and data linkage specifications for integrating this technology.
Phase 2: Prototype Development & Data Integration
Duration: 6 months
Develop a prototype by integrating the core module of this technology into existing systems based on defined requirements. Progress with blood data and health/lifestyle data linkage, and implement analysis algorithms.
Phase 3: Pilot Testing & Market Launch Preparation
Duration: 6 months
Conduct a small-scale pilot test using the developed prototype to verify accuracy and identify operational challenges. Optimize the system based on results and prepare for full-scale market introduction.
Technical Feasibility
This technology's functional configuration, which observes red blood cell membrane status from blood to collect health and lifestyle information, suggests it can be integrated as a software module into existing blood analysis devices and image analysis systems, as indicated in the patent specification. By leveraging general-purpose optical systems and image processing technologies, significant new capital investment is likely unnecessary, allowing licensees to quickly implement the technology by maximizing existing infrastructure. Blood collection can also be performed using simple methods, indicating low technical barriers to adoption.
Success Scenario
Upon adoption, companies could gain more detailed and real-time insights into employee health. This could enable early detection and intervention for health risks, potentially reducing employee healthcare costs by an estimated 15% annually. Furthermore, improved health management metrics could enhance corporate image and employee retention. The technology could also contribute to improving individual quality of life by providing personalized health advice.
Patent Record
APPLICATION NO.
特願2020-136647
REGISTRATION NO.
6864279
FILING DATE
2020/08/13
GRANT DATE
2021/04/06
EXPIRATION DATE
2040/08/13
PATENT HOLDER
株式会社宮本製作所
Examination History
2020年08月13日
早期審査に関する事情説明書
2020年08月21日
早期審査に関する報告書
2020年09月08日
手続補正書（自発・内容）
2020年11月10日
拒絶理由通知書
2020年12月28日
手続補正書（自発・内容）
2020年12月28日
意見書
2021年03月02日
特許査定